1st Quarter - Report

AVENUE SOLUTIONS for EXPRESS SCRIPTS INC

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to Medicare/Medicaid drug coverage including pharmacy payments (average manufacturer price), reimbursements, competition and plan administration, electronic prescribing, chronic care, PBM disclosure. HR 3200, America's Affordable Health Choices Act; HR 3590, Patient Protection and Affordable Care Act; HR 3962, Affordable Health Care for America Act - health reform proposals impacting prescription drug coverage including formulary requirements, generic drug co-payments,direct negotiation, Medicare/Medicaid rebate changes, closure of Part D coverage gap, retiree drug subsidy, pharmaceutical benefit manager excise tax, medication therapy management

LobbyistCovered position, as disclosed
ELIZABETH MACDONALD BARNETT —
TRACY SPICER —
AMY TEJRAL —

Contacted: Executive Office of the President (EOP); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 3962 (111th), H.R. 3200 (111th), H.R. 3590 (111th)

Pharmacy PHA

HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 1427, Promoting Innovation and Access to Life Saving Medicine Act - generic biologics; HR 1548, Pathway for Biosimilars Act - generic biologics; HR 1706, Protecting Consumer Access to Generic Drugs Act - generic drugs; HR 3200, America's Affordable Health Choices Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data minimg, pharmaceutical benefit manager excise tax, generic biologics; HR 3590, Patient Protection and Affordable Care Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics; HR 3962, Affordable Health Care for America Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics, generic prescription drugs; HR 4489, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act HR 4872, Health Care and Education Reconciliation Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics; S. 369, Preserve Access to Affordable Generics Act - generic drugs; S 726, Promoting Innovation and Access to Life-Saving Medicine Act - generic biologics; S 1630, Affordable Access to Prescription Medications Act - prescription drug co-pays and formularies; S 1679, Affordable Health Choices Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics; S 1796, American's Healthy Future Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics

LobbyistCovered position, as disclosed
ELIZABETH MACDONALD BARNETT —
TRACY SPICER —
AMY TEJRAL —

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1427 (111th), H.R. 1706 (111th), H.R. 3200 (111th), H.R. 1548 (111th), H.R. 1204 (111th), H.R. 4872 (111th), H.R. 3962 (111th), H.R. 3590 (111th), H.R. 4489 (111th), S. 369 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.